 Clinical pharmacology intravenous enoximone pharmacodynamics pharmacokinetics patients heart failure patients heart failure New York Heart Association NYHA class II IV infusion enoximone washout period Patients treatment groups Groups III mg/kg bolus maintenance infusion micrograms/kg/min Group IV patients maintenance infusion micrograms/kg/min loading dose Serial assessment hemodynamics plasma levels enoximone enoximone sulfoxide ventricular ectopy Enoximone significant increase cardiac index decrease mean pulmonary artery wedge pressure systemic vascular resistance groups increased heart rate minimal effect mean arterial pressure significant change ventricular ectopy infusion Significant hemodynamic improvement infusion rate linear fashion infusion rates patients initial loading bolus mg/kg increase cardiac index hour Plasma concentrations enoximone major metabolite infusion group III micrograms/kg/min steady state terminal exponential half-lives compounds suggestive nonlinear pharmacokinetics potential excessive accumulation enoximone metabolite prolonged infusion findings important implications intravenous administration enoximone